Article info

Download PDFPDF

Original research
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study

Authors

  1. Correspondence to Dr Lauren C Harshman; laurenC_harshman{at}dfci.harvard.edu
View Full Text

Citation

Martinez Chanza N, Xie W, Issa M, et al
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study

Publication history

  • Accepted February 14, 2020
  • First published March 26, 2020.
Online issue publication 
March 26, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.